UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Provider Barriers to Epinephrine Autoinjector Prescription in Patients with Anaphylaxis

Journal of allergy and clinical immunology, 2017-02, Vol.139 (2), p.AB223-AB223

2017

Volltextzugriff (PDF)

P258 Comparison of infusion duration and number of infusion sites for subcutaneous immunoglobulins (SCIG)

Annals of allergy, asthma, & immunology, 2016-11, Vol.117 (5), p.S99-S99

2016

Volltextzugriff (PDF)

Anaphylaxis to Mint in a 5 Year Old Boy: A Case Report

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB200-AB200

2015

Volltextzugriff (PDF)

O015 Tolerability of a new human immune globulin subcutaneous, 20% preparation in primary immunodeficiency diseases

Annals of allergy, asthma, & immunology, 2016-11, Vol.117 (5), p.S5-S6

2016

Volltextzugriff (PDF)

P254 Local adverse reactions decreased over time during IGHY treatment in patients with PIDD

Annals of allergy, asthma, & immunology, 2016-11, Vol.117 (5), p.S97-S98

2016

Volltextzugriff (PDF)

Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada

Journal of the American Society of Nephrology, 2000-05, Vol.11 (5), p.917-922

2000

Volltextzugriff (PDF)

Induction of tolerance in a patient with a history of exfoliative dermatitis to trimethoprim-sulfamethoxazole

Annals of allergy, asthma, & immunology, 2012-11, Vol.109 (5), p.360-361

2012

Volltextzugriff (PDF)

Systemic IgE-mediated hypersensitivity reaction to topical polymyxin B

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2019-02, Vol.7 (2), p.734-735

2019

Volltextzugriff (PDF)

Deep venous thrombosis: clinically silent in the intensive care unit

Journal of critical care, 2005-12, Vol.20 (4), p.334-340

2005

Volltextzugriff (PDF)

Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors

Critical care medicine, 2005-07, Vol.33 (7), p.1565-1571

2005

Volltextzugriff (PDF)

Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients

Intensive care medicine, 2005, Vol.31 (1), p.48-55

2005

Volltextzugriff (PDF)

DOP71 Efficacy of once-daily, orally administered obefazimod in patients with moderately to severely active UC at weeks 8, 48, and 96 broken down by induction treatment dose

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i203-i204

2024

Volltextzugriff (PDF)

DOP12 Efficacy and safety of obefazimod in UC patients at weeks 48 and 96 of an open-label maintenance study among clinical responders at week 8 of the Phase 2b induction trial

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i94-i95

2024

Volltextzugriff (PDF)

P985 Efficacy and safety of de-escalation from 50 mg to 25 mg of oral, once-daily, obefazimod for the third and fifth year of open-label maintenance treatment in patients with moderately to severely active ulcerative colitis (UC): An interim analysis

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1787-i1787

2024

Volltextzugriff (PDF)

Peritoneal membrane transport and hypoalbuminemia: cause or effect?

Peritoneal dialysis international, 2000-01, Vol.20 (1), p.14-18

2000

Volltextzugriff (PDF)

A novel mutation in two families with limb-girdle muscular dystrophy type 2C

Neurology, 2006-07, Vol.67 (1), p.167-169

2006

Volltextzugriff (PDF)

Benefit of continuous renal replacement therapy in subgroups of acutely ill patients: a retrospective analysis

Clinical nephrology, 2005-04, Vol.63 (4), p.267-275

2005

Volltextzugriff (PDF)

Multiple episodes of repetitive vomiting in a 5-year-old boy

Contemporary pediatrics (Montvale, N.J.), 2024-09, Vol.40 (8), p.11-13

2024

Volltextzugriff (PDF)

P476 Characterization of cardiac conduction abnormalities reported in the phase 3 ELEVATE programme

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i604-i606

2023

Volltextzugriff (PDF)

P407 Efficacy and safety of etrasimod in subjects with moderately to severely active isolated proctitis: a subgroup analysis of the phase 3 ELEVATE UC 52 and ELEVATE UC 12 trials

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i536-i538

2023

Volltextzugriff (PDF)

P582 Efficacy of etrasimod at week 52 among subjects who reached clinical response at week 12: post hoc analysis of the phase 3 ELEVATE UC 52 trial

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i709-i711

2023

Volltextzugriff (PDF)

P281 Adverse events and infusion parameters of IG20GLY in PIDD patients whose pre-study treatment was IVIG

Annals of allergy, asthma, & immunology, 2017-11, Vol.119 (5), p.S71-S72

2017

Volltextzugriff (PDF)

Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis

Journal of critical care, 2009-06, Vol.24 (2), p.168-175

2009

Volltextzugriff (PDF)

P279 Post-authorization safety study of hyaluronidase-facilitated subcutaneous immunoglobulin 10% treatment in patients with primary immunodeficiency diseases

Annals of allergy, asthma, & immunology, 2017-11, Vol.119 (5), p.S71-S71

2017

Volltextzugriff (PDF)

Impact of haemoglobin and erythropoietin dose changes on mortality: a secondary analysis of results from a randomized anaemia management trial

Nephrology, dialysis, transplantation, 2010-12, Vol.25 (12), p.4002-4009

2010

Volltextzugriff (PDF)

1 – 25 von 186

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(158)
Mit Volltextzugriff
(136)

Publikationsform

Sprache

Englisch
(138)
Französisch
(48)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Provider Barriers to Epinephrine Autoinjector Prescription in Patients with Anaphylaxis

P258 Comparison of infusion duration and number of infusion sites for subcutaneous immunoglobulins (SCIG)

Anaphylaxis to Mint in a 5 Year Old Boy: A Case Report

O015 Tolerability of a new human immune globulin subcutaneous, 20% preparation in primary immunodeficiency diseases

P254 Local adverse reactions decreased over time during IGHY treatment in patients with PIDD

Comparison of mortality risk for dialysis patients and cadaveric first renal transplant recipients in Ontario, Canada

Induction of tolerance in a patient with a history of exfoliative dermatitis to trimethoprim-sulfamethoxazole

Systemic IgE-mediated hypersensitivity reaction to topical polymyxin B

Deep venous thrombosis: clinically silent in the intensive care unit

Deep venous thrombosis in medical-surgical critically ill patients: Prevalence, incidence, and risk factors

Neither baseline tests of molecular hypercoagulability nor D-dimer levels predict deep venous thrombosis in critically ill medical-surgical patients

DOP71 Efficacy of once-daily, orally administered obefazimod in patients with moderately to severely active UC at weeks 8, 48, and 96 broken down by induction treatment dose

DOP12 Efficacy and safety of obefazimod in UC patients at weeks 48 and 96 of an open-label maintenance study among clinical responders at week 8 of the Phase 2b induction trial

P985 Efficacy and safety of de-escalation from 50 mg to 25 mg of oral, once-daily, obefazimod for the third and fifth year of open-label maintenance treatment in patients with moderately to severely active ulcerative colitis (UC): An interim analysis

Peritoneal membrane transport and hypoalbuminemia: cause or effect?

A novel mutation in two families with limb-girdle muscular dystrophy type 2C

Benefit of continuous renal replacement therapy in subgroups of acutely ill patients: a retrospective analysis

Multiple episodes of repetitive vomiting in a 5-year-old boy

P476 Characterization of cardiac conduction abnormalities reported in the phase 3 ELEVATE programme

P407 Efficacy and safety of etrasimod in subjects with moderately to severely active isolated proctitis: a subgroup analysis of the phase 3 ELEVATE UC 52 and ELEVATE UC 12 trials

P582 Efficacy of etrasimod at week 52 among subjects who reached clinical response at week 12: post hoc analysis of the phase 3 ELEVATE UC 52 trial

P281 Adverse events and infusion parameters of IG20GLY in PIDD patients whose pre-study treatment was IVIG

Event adjudication and data monitoring in an intensive care unit observational study of thromboprophylaxis

P279 Post-authorization safety study of hyaluronidase-facilitated subcutaneous immunoglobulin 10% treatment in patients with primary immunodeficiency diseases

Impact of haemoglobin and erythropoietin dose changes on mortality: a secondary analysis of results from a randomized anaemia management trial

Suchergebnisse filtern